Picture of the autors of the research (IMAGE)
Caption
Dimitrije Ivančić (co-first author of the paper), Avencia Sanchez-Mejías (CEO of Integra Therapeutics),
Alejandro Agudelo (co-first author of the paper) and Marc Güell (ICREA researcher and CSO of Integra Therapeutics)
Credit
Integra Therapeutics
Usage Restrictions
none
License
Original content